PARIS--(BUSINESS WIRE)--Regulatory News:
BioAlliance Pharma SA (Paris:BIO), a Company dedicated to specialty and orphan pharma products in oncology and supportive care, has successfully held its first symposium today at its headquarter in Paris, with about 50 shareholders, fund managers, analysts and media representatives.
